Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung Cancer.

Reck M, Horn L, Novello S, Barlesi F, Albert I, Juhász E, Kowalski D, Robinet G, Cadranel J, Bidoli P, Chung J, Fritsch A, Drews U, Wagner A, Govindan R.

J Thorac Oncol. 2019 Apr;14(4):701-711. doi: 10.1016/j.jtho.2019.01.010. Epub 2019 Jan 21. Erratum in: J Thorac Oncol. 2019 Aug;14(8):1484.

PMID:
30677506
2.

The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Final results of AVALANCHE, an observational cohort study.

Tolnay E, Ghimessy ÁK, Juhász E, Sztancsik Z, Losonczy G, Dombi P, Vennes Z, Helf L, Csada E, Sárosi V.

Oncol Lett. 2019 Feb;17(2):1750-1760. doi: 10.3892/ol.2018.9766. Epub 2018 Nov 27.

3.

The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.

Bartus A, Palasti F, Juhasz E, Kiss E, Simonova E, Sumanszki C, Reismann P.

Metab Brain Dis. 2018 Oct;33(5):1609-1615. doi: 10.1007/s11011-018-0267-6. Epub 2018 Jun 12.

PMID:
29948654
4.

Eikenella corrodens retroperitoneal necrotising fasciitis post-endoscopic retrograde cholangio-pancreatography.

Lin YS, Juhasz ES.

N Z Med J. 2018 May 4;131(1474):69-73. No abstract available.

PMID:
29723181
5.

Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Nonsquamous Non-Small Cell Lung Cancer.

von Pawel J, Spigel DR, Ervin T, Losonczy G, Barlesi F, Juhász E, Anderson M, McCall B, Wakshull E, Hegde P, Ye W, Chen D, Chang I, Rhee I, Reck M.

Oncologist. 2018 Jun;23(6):654-e58. doi: 10.1634/theoncologist.2017-0690. Epub 2018 Feb 7.

6.

A multicentre survey of the antibiotic susceptibility of clinical Bacteroides species from Hungary.

Sárvári KP, Sóki J, Kristóf K, Juhász E, Miszti C, Latkóczy K, Melegh SZ, Urbán E.

Infect Dis (Lond). 2018 May;50(5):372-380. doi: 10.1080/23744235.2017.1418530. Epub 2018 Jan 5.

PMID:
29303023
7.

[Uncommon non-fermenting Gram-negative rods as pathogens of lower respiratory tract infection].

Juhász E, Iván M, Pongrácz J, Kristóf K.

Orv Hetil. 2018 Jan;159(1):23-30. doi: 10.1556/650.2018.30926. Hungarian.

PMID:
29291642
8.

Evaluation of potential reference genes for real-time qPCR analysis in a biparental beetle, Lethrus apterus (Coleoptera: Geotrupidae).

Nagy NA, Németh Z, Juhász E, Póliska S, Rácz R, Kosztolányi A, Barta Z.

PeerJ. 2017 Nov 28;5:e4047. doi: 10.7717/peerj.4047. eCollection 2017.

9.

Molecular characterisation of multidrug-resistant Bacteroides isolates from Hungarian clinical samples.

Sárvári KP, Sóki J, Kristóf K, Juhász E, Miszti C, Melegh SZ, Latkóczy K, Urbán E.

J Glob Antimicrob Resist. 2018 Jun;13:65-69. doi: 10.1016/j.jgar.2017.10.020. Epub 2017 Oct 31.

PMID:
29101081
10.

Colistin resistance among blood culture isolates at a tertiary care centre in Hungary.

Juhász E, Iván M, Pintér E, Pongrácz J, Kristóf K.

J Glob Antimicrob Resist. 2017 Dec;11:167-170. doi: 10.1016/j.jgar.2017.08.002. Epub 2017 Aug 21.

PMID:
28838854
11.

Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non-Small Cell Lung Cancer.

Reck M, Blais N, Juhasz E, Gorbunova V, Jones CM, Urban L, Orlov S, Barlesi F, Kio E, Keilholz U, Qin Q, Qian J, Nickner C, Dziubinski J, Xiong H, Mittapalli RK, Dunbar M, Ansell P, He L, McKee M, Giranda V, Ramalingam SS.

J Thorac Oncol. 2017 Jul;12(7):1098-1108. doi: 10.1016/j.jtho.2017.04.010. Epub 2017 Apr 29.

12.

Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non-Small Cell Lung Cancer.

Ramalingam SS, Blais N, Mazieres J, Reck M, Jones CM, Juhasz E, Urban L, Orlov S, Barlesi F, Kio E, Keiholz U, Qin Q, Qian J, Nickner C, Dziubinski J, Xiong H, Ansell P, McKee M, Giranda V, Gorbunova V.

Clin Cancer Res. 2017 Apr 15;23(8):1937-1944. doi: 10.1158/1078-0432.CCR-15-3069. Epub 2016 Oct 10.

13.

Serum prolactin as a biomarker for the study of intracerebral dopamine effect in adult patients with phenylketonuria: a cross-sectional monocentric study.

Juhász E, Kiss E, Simonova E, Patócs A, Reismann P.

Eur J Med Res. 2016 May 11;21(1):22. doi: 10.1186/s40001-016-0212-2.

14.

Accuracy of machine learning classifiers using bilateral data from a Scheimpflug camera for identifying eyes with preclinical signs of keratoconus.

Kovács I, Miháltz K, Kránitz K, Juhász É, Takács Á, Dienes L, Gergely R, Nagy ZZ.

J Cataract Refract Surg. 2016 Feb;42(2):275-83. doi: 10.1016/j.jcrs.2015.09.020.

PMID:
27026453
15.

Does Staphylococcus Saprophyticus Cause Acute Cystitis only in Young Females, or is there more to the Story? A One-Year Comprehensive Study Done in Budapest, Hungary.

Adeghate J, Juhász E, Pongrácz J, Rimanóczy É, Kristóf K.

Acta Microbiol Immunol Hung. 2016 Mar;63(1):57-67. doi: 10.1556/030.63.2016.1.4.

PMID:
27020869
16.

Monotherapy Administration of Sorafenib in Patients With Non-Small Cell Lung Cancer (MISSION) Trial: A Phase III, Multicenter, Placebo-Controlled Trial of Sorafenib in Patients with Relapsed or Refractory Predominantly Nonsquamous Non-Small-Cell Lung Cancer after 2 or 3 Previous Treatment Regimens.

Paz-Ares L, Hirsh V, Zhang L, de Marinis F, Yang JC, Wakelee HA, Seto T, Wu YL, Novello S, Juhász E, Arén O, Sun Y, Schmelter T, Ong TJ, Peña C, Smit EF, Mok TS.

J Thorac Oncol. 2015 Dec;10(12):1745-53. doi: 10.1097/JTO.0000000000000693.

17.

In vitro biofilm production of Candida bloodstream isolates: any association with clinical characteristics?

Pongrácz J, Benedek K, Juhász E, Iván M, Kristóf K.

J Med Microbiol. 2016 Apr;65(4):272-7. doi: 10.1099/jmm.0.000207. Epub 2015 Dec 17.

PMID:
26678484
18.

Significance of yeasts in bloodstream infection: Epidemiology and predisposing factors of Candidaemia in adult patients at a university hospital (2010-2014).

Pongrácz J, Juhász E, Iván M, Kristóf K.

Acta Microbiol Immunol Hung. 2015 Sep;62(3):317-29. doi: 10.1556/030.62.2015.3.9.

PMID:
26551574
19.

Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.

Juhász E, Pongrácz J, Iván M, Kristóf K.

Acta Microbiol Immunol Hung. 2015 Sep;62(3):295-305. doi: 10.1556/030.62.2015.3.7.

PMID:
26551572
20.

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer.

Giaccone G, Bazhenova LA, Nemunaitis J, Tan M, Juhász E, Ramlau R, van den Heuvel MM, Lal R, Kloecker GH, Eaton KD, Chu Q, Dunlop DJ, Jain M, Garon EB, Davis CS, Carrier E, Moses SC, Shawler DL, Fakhrai H.

Eur J Cancer. 2015 Nov;51(16):2321-9. doi: 10.1016/j.ejca.2015.07.035. Epub 2015 Aug 14.

PMID:
26283035
21.

Flap thickness in femtosecond laser.

Juhasz E.

J Refract Surg. 2015 Feb;31(2):140. No abstract available.

PMID:
25793238
22.

Evaluation of the mechanical properties of the anterior lens capsule following femtosecond laser capsulotomy at different pulse energy settings.

Sándor GL, Kiss Z, Bocskai ZI, Kolev K, Takács ÁI, Juhász É, Kránitz K, Tóth G, Gyenes A, Bojtár I, Juhász T, Nagy ZZ.

J Refract Surg. 2015 Mar;31(3):153-7. doi: 10.3928/1081597X-20150220-02.

PMID:
25751830
23.

Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS Mutations.

Garay T, Molnár E, Juhász É, László V, Barbai T, Dobos J, Schelch K, Pirker C, Grusch M, Berger W, Tímár J, Hegedűs B.

Pathol Oncol Res. 2015 Sep;21(4):957-68. doi: 10.1007/s12253-015-9916-9. Epub 2015 Mar 9.

PMID:
25749811
24.

Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells.

Garay T, Kenessey I, Molnár E, Juhász É, Réti A, László V, Rózsás A, Dobos J, Döme B, Berger W, Klepetko W, Tóvári J, Tímár J, Hegedűs B.

PLoS One. 2015 Feb 3;10(2):e0117021. doi: 10.1371/journal.pone.0117021. eCollection 2015.

25.

Infection and colonization by Stenotrophomonas maltophilia: antimicrobial susceptibility and clinical background of strains isolated at a tertiary care centre in Hungary.

Juhász E, Krizsán G, Lengyel G, Grósz G, Pongrácz J, Kristóf K.

Ann Clin Microbiol Antimicrob. 2014 Dec 31;13:333. doi: 10.1186/s12941-014-0058-9.

26.

Evaluation of intereye corneal asymmetry in patients with keratoconus. A scheimpflug imaging study.

Dienes L, Kránitz K, Juhász E, Gyenes A, Takács A, Miháltz K, Nagy ZZ, Kovács I.

PLoS One. 2014 Oct 8;9(10):e108882. doi: 10.1371/journal.pone.0108882. eCollection 2014.

27.

Comparison of the mechanical properties of the anterior lens capsule following manual capsulorhexis and femtosecond laser capsulotomy.

Sándor GL, Kiss Z, Bocskai ZI, Kolev K, Takács AI, Juhász E, Kránitz K, Tóth G, Gyenes A, Bojtár I, Juhász T, Nagy ZZ.

J Refract Surg. 2014 Oct;30(10):660-4. doi: 10.3928/1081597X-20140903-08.

PMID:
25291748
28.

Analysis of planned and postoperatively measured flap thickness after LASIK using the LenSx multifunctional femtosecond laser system.

Juhasz E, Filkorn T, Kranitz K, Sandor GL, Gyenes A, Nagy ZZ.

J Refract Surg. 2014 Sep;30(9):622-6.

PMID:
25250419
29.

[Special application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry in clinical microbiological diagnostics].

Nagy E, Abrók M, Bartha N, Bereczki L, Juhász E, Kardos G, Kristóf K, Miszti C, Urbán E.

Orv Hetil. 2014 Sep 21;155(38):1495-503. doi: 10.1556/OH.2014.29985. Review. Hungarian.

PMID:
25217765
30.

Clinical genotyping and efficacy outcomes: exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer.

Pallaud C, Reck M, Juhasz E, Szima B, Yu CJ, Burdaeva O, Orlov S, Hilton M, Archer V, Mok T.

Lung Cancer. 2014 Oct;86(1):67-72. doi: 10.1016/j.lungcan.2014.07.019. Epub 2014 Aug 2.

PMID:
25154982
31.

Scheimpflug imaging for long-term evaluation of optical components in Hungarian children with a history of preterm birth.

Ecsedy M, Kovacs I, Mihaltz K, Recsan Z, Szigeti A, Juhasz E, Nemeth J, Nagy ZZ.

J Pediatr Ophthalmol Strabismus. 2014 Jul 1;51(4):235-41. doi: 10.3928/01913913-20140521-04. Epub 2014 May 28.

PMID:
24877551
32.

A correlative biomarker analysis of the combination of bevacizumab and carboplatin-based chemotherapy for advanced nonsquamous non-small-cell lung cancer: results of the phase II randomized ABIGAIL study (BO21015).

Mok T, Gorbunova V, Juhasz E, Szima B, Burdaeva O, Orlov S, Yu CJ, Archer V, Hilton M, Delmar P, Pallaud C, Reck M.

J Thorac Oncol. 2014 Jun;9(6):848-55. doi: 10.1097/JTO.0000000000000160.

33.

Changes of corneal topography indices after CXL in progressive keratoconus assessed by Scheimpflug camera.

Kránitz K, Kovács I, Miháltz K, Sándor GL, Juhász É, Gyenes A, Nagy ZZ.

J Refract Surg. 2014 Jun;30(6):374-8. doi: 10.3928/1081597X-20140401-01. Epub 2014 Apr 8.

PMID:
24708090
34.

Complications of femtosecond laser-assisted cataract surgery.

Nagy ZZ, Takacs AI, Filkorn T, Kránitz K, Gyenes A, Juhász É, Sándor GL, Kovacs I, Juhász T, Slade S.

J Cataract Refract Surg. 2014 Jan;40(1):20-8. doi: 10.1016/j.jcrs.2013.08.046.

PMID:
24355719
35.

Wavefront properties of the anterior and posterior corneal surface after photorefractive keratectomy.

Juhasz E, Kranitz K, Sandor GL, Gyenes A, Toth G, Nagy ZZ.

Cornea. 2014 Feb;33(2):172-6. doi: 10.1097/ICO.0000000000000035.

PMID:
24326331
36.

Cell migration or cytokinesis and proliferation?--revisiting the "go or grow" hypothesis in cancer cells in vitro.

Garay T, Juhász É, Molnár E, Eisenbauer M, Czirók A, Dekan B, László V, Hoda MA, Döme B, Tímár J, Klepetko W, Berger W, Hegedűs B.

Exp Cell Res. 2013 Dec 10;319(20):3094-103. doi: 10.1016/j.yexcr.2013.08.018. Epub 2013 Aug 22.

PMID:
23973668
37.

A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC).

Groen HJ, Socinski MA, Grossi F, Juhasz E, Gridelli C, Baas P, Butts CA, Chmielowska E, Usari T, Selaru P, Harmon C, Williams JA, Gao F, Tye L, Chao RC, Blumenschein GR Jr.

Ann Oncol. 2013 Sep;24(9):2382-9. doi: 10.1093/annonc/mdt212. Epub 2013 Jun 20.

38.

Effects of erlotinib first-line maintenance therapy versus placebo on the health-related quality of life of patients with metastatic non-small-cell lung cancer.

Juhász E, Kim JH, Klingelschmitt G, Walzer S.

Eur J Cancer. 2013 Apr;49(6):1205-15. doi: 10.1016/j.ejca.2012.11.006. Epub 2013 Mar 7.

PMID:
23477998
39.

Laser refractive cataract surgery with a femtosecond laser after penetrating keratoplasty: case report.

Nagy ZZ, Takács ÁI, Filkorn T, Juhász É, Sándor G, Szigeti A, Knorz MC.

J Refract Surg. 2013 Jan;29(1):8. doi: 10.3928/1081597X-20121228-01. No abstract available.

PMID:
23311734
40.

Sunitinib plus erlotinib for the treatment of advanced/metastatic non-small-cell lung cancer: a lead-in study.

Blumenschein GR Jr, Ciuleanu T, Robert F, Groen HJ, Usari T, Ruiz-Garcia A, Tye L, Chao RC, Juhasz E.

J Thorac Oncol. 2012 Sep;7(9):1406-16.

41.

Emergence of VIM-4- and SHV-12-producing Enterobacter cloacae in a neonatal intensive care unit.

Juhász E, Jánvári L, Tóth A, Damjanova I, Nobilis A, Kristóf K.

Int J Med Microbiol. 2012 Nov;302(6):257-60. doi: 10.1016/j.ijmm.2012.05.003. Epub 2012 Jun 20.

PMID:
22721811
42.

Randomized phase 2b study of pralatrexate versus erlotinib in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) after failure of prior platinum-based therapy.

Kelly K, Azzoli CG, Zatloukal P, Albert I, Jiang PY, Bodkin D, Pereira JR, Juhász E, Iannotti NO, Weems G, Koutsoukos T, Patel JD.

J Thorac Oncol. 2012 Jun;7(6):1041-8. doi: 10.1097/JTO.0b013e31824cc66c.

43.

Reduced physical fitness in children and adolescents with type 1 diabetes.

Lukács A, Mayer K, Juhász E, Varga B, Fodor B, Barkai L.

Pediatr Diabetes. 2012 Aug;13(5):432-7. doi: 10.1111/j.1399-5448.2012.00848.x. Epub 2012 Feb 21.

PMID:
22353226
44.

Expression of tight junction molecules in breast carcinomas analysed by array PCR and immunohistochemistry.

Tőkés AM, Szász AM, Juhász E, Schaff Z, Harsányi L, Molnár IA, Baranyai Z, Besznyák I Jr, Zaránd A, Salamon F, Kulka J.

Pathol Oncol Res. 2012 Jul;18(3):593-606. doi: 10.1007/s12253-011-9481-9. Epub 2011 Dec 23.

PMID:
22193974
45.

Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.

Soria JC, Márk Z, Zatloukal P, Szima B, Albert I, Juhász E, Pujol JL, Kozielski J, Baker N, Smethurst D, Hei YJ, Ashkenazi A, Stern H, Amler L, Pan Y, Blackhall F.

J Clin Oncol. 2011 Nov 20;29(33):4442-51. doi: 10.1200/JCO.2011.37.2623. Epub 2011 Oct 17.

PMID:
22010015
46.

HVS-I polymorphism screening of ancient human mitochondrial DNA provides evidence for N9a discontinuity and East Asian haplogroups in the Neolithic Hungary.

Guba Z, Hadadi É, Major Á, Furka T, Juhász E, Koós J, Nagy K, Zeke T.

J Hum Genet. 2011 Nov;56(11):784-96. doi: 10.1038/jhg.2011.103. Epub 2011 Sep 15.

PMID:
21918529
47.

The Consequence of a Founder Effect: CCR5-∆32, CCR2-64I and SDF1-3'A Polymorphism in Vlach Gypsy Population in Hungary.

Juhász E, Béres J, Kanizsai S, Nagy K.

Pathol Oncol Res. 2012 Apr;18(2):177-82. doi: 10.1007/s12253-011-9425-4. Epub 2011 Jun 11.

PMID:
21667221
48.

Evolution and predictors of morphological and functional arterial changes in the course of type 1 diabetes mellitus.

Vastagh I, Horváth T, Nagy G, Varga T, Juhász E, Juhász V, Kollai M, Bereczki D, Somogyi A.

Diabetes Metab Res Rev. 2010 Nov;26(8):646-55. doi: 10.1002/dmrr.1133. Epub 2010 Oct 4.

PMID:
20922819
49.

Significance and imaging of lumbar veins and early-branching arteries in planning living-donor laparoscopic nephrectomy: two case reports from 21 months' experience.

Deák PA, Doros A, Lovró Z, Juhász E, Branstetter G, Kovács JB, Piros L, Járay J.

Transplant Proc. 2010 Jul-Aug;42(6):2347-9. doi: 10.1016/j.transproceed.2010.05.019.

PMID:
20692477
50.

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study.

Cappuzzo F, Ciuleanu T, Stelmakh L, Cicenas S, Szczésna A, Juhász E, Esteban E, Molinier O, Brugger W, Melezínek I, Klingelschmitt G, Klughammer B, Giaccone G; SATURN investigators.

Lancet Oncol. 2010 Jun;11(6):521-9. doi: 10.1016/S1470-2045(10)70112-1. Epub 2010 May 20.

PMID:
20493771

Supplemental Content

Loading ...
Support Center